East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...

Kirkland & Ellis announced the hire Wednesday of a three-partner M&A team from Skadden, Arps, Slate, Meagher & Flom, on the ...

Some of it is in the new Boston home of Eli Lilly & Co ., a $700 million research and development facility along Fort Point ...

The Massachusetts-based Organogenesis is developing a biomanufacturing facility at 100 Technology Way in Smithfield, Rhode ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

A Cambridge-based pharmaceutical company is laying off close to a hundred ... Beth Treffeisen is a general assignment reporter for Boston.com, focusing on local news, crime, and business in ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

An international pharmaceutical research company will lay off 83 Boston-area employees by the end of June, according to new filings with the state. Ono Pharma, the United States subsidiary of a ...